Ivim Health vs Novi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

53 providers verified independently·Independent researchHow we rank →

Ivim Health beats Novi overall, scoring 7.9/10 vs 7.8/10. Novi is more affordable at $133/mo vs $150/mo. Choose Ivim Health for users who want personalized dosing with frequent provider ch. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.

A side-by-side look at Ivim Health and Novi to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for
Higher Rated

Ivim Health

#8 of 53
7.9/10

Personalized GLP-1 program with frequent provider check-ins and customized dosing schedules at an affordable price point.

Visit Ivim Health

Novi

#12 of 53
7.8/10

Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing, medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.

Visit Novi
FeatureIvim HealthNovi
Our Score7.9/107.8/10
Starting Price$150/mo$133/mo
Medication TypeBothCompounded
Insurance AcceptedNoNo
Best ForUsers who want personalized dosing with frequent provider check-insCash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer
Watch out forThe $75/mo starting price increases with dose, expect $150-200/mo at maintenance dosesCompounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
Ranking#8#12
Get startedVisit Ivim HealthVisit Novi

Pros & Cons Compared

Ivim Health

Pros

  • +$75/mo starting price is among the lowest in the market for a program with actual provider oversight
  • +Bi-weekly provider check-ins included, more frequent than most platforms at this price point
  • +Personalized titration schedules based on individual tolerance, not cookie-cutter dose escalation
  • +Both brand-name and compounded available, with the option to switch based on response

Cons

  • The $75/mo starting price increases with dose, expect $150-200/mo at maintenance doses
  • No insurance billing, and the cost increase at higher doses isn't always clearly communicated upfront

Novi

Pros

  • +Six disclosed clinicians on staff, Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP), more named providers than most compounded-only platforms publish
  • +Month-to-month billing with no minimum commitment, cancel before any renewal date with no early-termination penalty
  • +Aggressive promotional pricing on the offer landing, $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
  • +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
  • +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
  • +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal

Cons

  • Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
  • Founding year, headquarters city, and corporate ownership are not publicly disclosed
  • Promotional $99-$133 pricing applies to the introductory offer landing only, standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
  • Once medication is dispensed/shipped, prescriptions cannot be returned or refunded, typical for compounded telehealth but worth understanding
  • Lab requirements before prescribing are not disclosed on public pages, unclear whether baseline bloodwork is required
  • Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout

Our Verdict

Ivim Health edges out Novi with a score of 7.9/10 vs 7.8/10. If budget is your priority, Novi starts at $133/mo compared to Ivim Health's $150/mo. Ivim Health offers both brand-name and compounded medications, giving you more flexibility. Choose Ivim Health if you want: users who want personalized dosing with frequent provider check-ins. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.

Still undecided? Editor's Featured Pick

TrimRx

$149/mo · 7.8/10 · Compounded

If neither Ivim Health nor Novi feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.

Try Ivim Health

Starting at $150/mo

Visit Ivim Health

Try Novi

Starting at $133/mo

Visit Novi

Related comparisons

Other matchups readers comparing Ivim Health or Novi tend to look at next.

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Featured Partners

Four affiliate partners we feature, we may earn a commission.

TrimRx

7.8/10
$149/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Embody

7.3/10
$149/mo·Compounded

SkinnyRx

7.3/10
$199/mo·Compounded

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. The objective ranking (by methodology score) and full methodology are at glp1picks.com/best.